THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR QUOTATIONS (RFQ); NO CONTRACT WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT.
This synopsis is for information and planning purposes only and is not to be construed as a commitment by the government. This is NOT a Request for Proposal, Invitation for Bid, or an announcement of a solicitation. Response to this SOURCES SOUGHT is strictly voluntary and will not affect any firms' ability to submit an offer if a solicitation is released. There is no bid package or solicitation document associated with this announcement. The purpose of this document is to identify potential sources. Any requests for a solicitation package will be disregarded. The Government does not intend to award a contract on the basis of this source sought or otherwise pay for the information solicited. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of preparing submissions in response to this sources sought and the Government's use of such information.
This sources sought is being conducted to identify potential Small Manufactures/Authorized Distributors capable of producing or supplying Brand Name Supplies.

SCOPE OF WORK

Catalog Number Description Quantity
81000 Trima Collection System 1 each
777-098-897 Trima Seal Safe System 1 each

Period of Performance:
October 1, 2017

Delivery Schedule:
N/A

Scope of Work:
Trima Accel automated blood cell separators are required to replace the current COBE Spectras that are being phased out completely by the vendor on December 31, 2017. Our intention is to avoid any disruption in the care and treatment of patients who are treated at the NIH, as they do not have any other available treatment options. Having the new separators will ensure that our cellular collections will continue to support the clinical center patients and research efforts currently being pursued and allow for efficient and quality cellular collections.

Objective:
The purpose of this procurement is to acquire a new automated blood cell separator to replace the existing COBE Spectra Blood cell separators that have been in used for 30+ years. Terumo, Blood Component Technology (BCT) which manufactures the COBE Spectra has notified users that as of December 31, 2017, all sales of units, tubing sets, spare parts, accessories and maintenance support will cease. The DTM needs to have the new blood cell separators in place by October 2017 in order to allow for validation and training of staff prior to the end of 2017. Continuity is a must as these systems are essential for collections of cellular components for transfusion at the NIH Clinical Center. The Trima Accel system will allow diversity in the collection of transfusable components by apheresis.

CAPABILITY STATEMENT - Any potential Manufacturer must demonstrate the following:
1) The offeror shall submit product literature for the supplies it is proposing. Capability Statement(s) should clearly identify the following:
a. Name of the Manufacturer, quantity and location where the units are produced (domestic and/or international);
b. A signed statement to state, "We are the Manufacturer of the items and/or we are authorized distributors of company X";
c. Estimated Number of days, after receipt of order that is typical for delivery of such items;
d. Any other relevant information that is not listed above which the Government should consider in developing its minimum specifications and finalizing its market research.

2) Provide the following business information:
a. DUNS number
b. Company Name
c. Company Address (including point of contact, phone number and email address)
d. Type/Size of company, NAICS code as validated in SAMS.
Respondents will NOT be notified of the results of the evaluation.

Bid Protests Not Available